Issue 1: Welcome to the Pharma Digest
Issue 1: Welcome to the Pharma Digest
Welcome to your NEW bi-weekly Digest.
The industry has never been more primed to drive positive change, however post-Covid health systems are at their limit, so pharma must again evolve to take the lead. Keeping your organisation up to speed can be tricky - we're here to help solve that problem.
Pharma Digest is a bi-weekly newsletter, hand-crafted by our Pharma team. We collate breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Each fortnight, we'll be bringing the latest market movements straight to your feed.
The Digest is for you, the valued members of our Pharma community. If you have ideas, suggestions, or questions for the team, don't hesitate to let us know in the comments, or get in touch directly.
Don't forget to subscribe to the Digest to receive your curated pharma content.
Let's get started.
Latest Webinar – Medical Affairs Data Centricity
With data giants about to disrupt the market, it is paramount Medical Affairs remain the first contact for HCPs and patients – we must continue to evolve and build a scientific narrative rich with data to truly improve patient outcomes.
Reuters Events have convened a panel of experts from Bayer, AstraZeneca, Novartis and more, to deep-dive the value of data across the lifecycle, and how Medical can move towards a brighter future: Medical Affairs Data Centricity on February 16th, 4pm GMT/5pm CET.
The evolution of omnichannel HCP engagement – your vital feedback
With HCP engagement rapidly evolving, we're running a global industry survey to understand what the future of innovative HCP engagement is and current trends amongst pharma marketeers and medical affairs execs. The survey is open to those working in pharma and biotech companies, and we'd love to have your input. You’ll be the first to receive the report with the findings and expert analysis.
Please share your thoughts, (it’s anonymous) in this short 10-minute survey.
This Week's Top 5 Pharma News to Watch
1. U.S. proposes Medicare, Medicaid programs to cut drug costs, including $2 generics (Reuters.com, February 15)
2. South Korea approves its first digital therapeutic (Pharmaphorum, February 15)
3. Bayer's new CEO has a full in-tray as investors push for change (Reuters.com, February 9)
4. Genentech plugs $450M into next-gen biologics plant in California, where it'll hire 150 (Fierce Pharma, February 13)
5. AstraZeneca Looks for Growth With New Drugs as COVID Sales Wane (PharmaExec, February 13)
Recommended by LinkedIn
Reuters Events: Pharma 2023 is the place where patient experts and pharma changemakers – from commercial, marketing, medical affairs, patient engagement, market access, RWE and Digital Health – share new best-practice, lessons learned and strategies for the future.
This week only: Use code VIPUPGRADE on business passes purchased by 17 Feb. Save €500 and access annual learnings!
Join us at Reuters Events: Pharma USA 2023 where North America’s visionary pharma changemakers, leading solution providers, patient experts, and industry heavyweights – from across Commercial, Marketing, Medical, Patient, Access, RWE and Cell & Gene Therapy - will catapult commercial excellence, guarantee equitable access to healthcare and accelerate cross-industry partnerships.
That rounds off Issue 1 of the Pharma Digest.
We'll be back in two weeks with more important news, market updates, pharma content, and updates on our events. Don’t forget to subscribe to receive a notification for our next digest.
As always, the Pharma team are on hand to answer your questions. You can connect with us on LinkedIn.
USA Team
Kana Hutton – Marketing/ Commercial
Hannah Brady – Medical Affairs
Daisy Beale – Patient/ Cell and Gene
Charlotte Bastiaanse – RWE/ Market Access
EU Team
Daniel Baker – Marketing/ Commercial
Joey Buchholz – Medical Affairs
Usmaan Khan – Patient
Charlotte Bastiaanse – RWE/ Market Access
See you next time!